Novo Nordisk

Back to home


Turoctocog Alfa Pegol
 


Predictive Modelling: Identifies Response To Fixed-Dose N8-Gp Prophylaxis In The First Weeks Of Treatment As A Predictor Of Long-Term Outcomes

Authors
Chowdary P et al.


© 2020 Novo Nordisk A/S Data privacy Cookie Policy